If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
105.80    2.60 (2.52%)
Bid:
105.60
Ask:
106.20
Spread: 0.60 (0.568%)
Market Cap: £444.73m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Director/PDMR Shareholding

3 Feb 2010 18:00

RNS Number : 6546G
PZ CUSSONS PLC
03 February 2010
 



PZ Cussons Plc (the "Company")

Announcement regarding dealing in shares

This notification is made in accordance with DR 3.1.4R(1)(a).

On 3 February 2010 Mr A Kanellis exercised options granted to him under the Company's Executive Share Option Scheme ("the ESOS") over 313,799 ordinary shares of 1p in the Company at the following exercise prices:

214,010 shares at £0.747 per share

99,789 shares at £1.104 per share

He subsequently sold 179,558 ordinary shares to the Paterson Zochonis Employee Trust ("the Trust") on 3 February for a consideration of £2.5480 per share. Mr Kanellis is Chief Executive of the Company and the Company was informed by Mr Kanellis of this dealing on 3 February. After this sale, Mr Kanellis holds 262,239 ordinary shares in the Company (comprising 0.06% of the total shares in issue).

 

On 3 February 2010 Mr C Davis exercised options granted to him under the Company's Executive Share Option Scheme over 242,040 ordinary shares of 1p in the Company at the following exercise prices:

76,900 shares at £0.747 per share

31,170 shares at £1.104 per share

 

62,900 shares at £1.298 per share

 

71,070 shares at £1.407 per share

 

He subsequently sold 242,040 ordinary shares to the Trust on 3 February for a consideration of £2.5480 per share. Mr Davis is Commercial Director of the Company and the Company was informed by Mr Davis of this dealing on 3 February. After this sale, Mr Davis holds 170,761 ordinary shares in the Company (comprising 0.04% of the total shares in issue).

The Trust is a discretionary trust under which the class of beneficiaries who may benefit comprises all bona fide employees and former employees of the Company and its subsidiaries including members of such employees' and former employees' immediate families. Accordingly, the Executive Directors and PDMRs of the Company are included in the class of beneficiaries and are deemed to have an interest in all of such shares. The Trust's holding in the ordinary shares of 1p in the Company after the dealings listed above is 1,122,496 shares (0.26%).

 

On 1 February 2010 Mr Chris How, who has been designated by the Board of the Directors of the Company as a person discharging managerial responsibility, sold 15,000 ordinary shares for a consideration of £2.45 per share. After this sale, Mr How holds 39,509 ordinary shares in the Company (comprising less than 0.01% of the total shares in issue). The Company was informed by Mr How of this dealing in shares on 1 February.

 

No new shares have been issued in respect of any of the dealings above. The current issued share capital of the company is 428,724,960 ordinary shares of 1p each.

Name of contact and telephone number for queries:

Sam Plant, Company Secretary, PZ Cussons Plc, (T) (00) 44 (0)161 491 8000

Date: 3 February 2010

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSTJMRTMBAMBRM
Date   Source Headline
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.